Strongbridge Biopharma - M&A Summary, Ownership, and Business Overview

Life ScienceCompany

Strongbridge Biopharma M&A Summary

Strongbridge Biopharma has acquired 1 company of its own.

Strongbridge Biopharma’s largest acquisition to date was in 2016, when it acquired Taro Pharmaceutical Industries - U.S. Rights to KEVEYIS for $9M. Strongbridge Biopharma has acquired in 1 US state. The Company’s most targeted sectors include life science (100%).

Strongbridge Biopharma Ownership

Who owns Strongbridge Biopharma?

Strongbridge Biopharma is owned by Xeris Pharmaceuticals. It was acquired on May 24, 2021.

Strongbridge Biopharma Business Overview

Where is Strongbridge Biopharma headquartered?

Strongbridge Biopharma is headquartered in Trevose, Pennsylvania.

What is Strongbridge Biopharma’s revenue?

Strongbridge Biopharma disclosed revenue of 31M USD for 2020 and 22M USD for 2019.

What sector is Strongbridge Biopharma in?

Strongbridge Biopharma is a life science company.

When was Strongbridge Biopharma founded?

Strongbridge Biopharma was founded in 1996.

M&A Summary

  • M&A Total Activity1
    • M&A Buy Activity1
  • Total Sectors Invested 1
  • Total Countries Invested 1
  • M&A Buy/Sell Connections 1
  • M&A Advisors 1

Strongbridge Biopharma

Strongbridge Biopharma plc

900 Northbrook Drive, Suite 200,
Trevose, Pennsylvania 19053
United States,
(610) 254-9200
www.strongbridgebio.com

Strongbridge Biopharma is a global commercial-stage biopharmaceutical company focused on the development and commercialization of therapies for rare diseases with significant unmet needs. Strongbridge's first commercial product is KEVEYIS® (dichlorphenamide), the first and only FDA-approved treatment for hyperkalemic, hypokalemic, and related variants of Primary Periodic Paralysis. Strongbridge Biopharma was founded in 1996 and is based in Trevose, Pennsylvania.


M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (0.0/yr) # 1 - - - - - 1
vol $9M $9M
Sell (0.0/yr) # - - - - - - 0
  1

Most Recent M&A

Company Date Value Type
Taro Pharmaceutical Industries Ltd. - U.S. Rights to KEVEYIS 2016-12-23 9M USD Divestiture
Trevose, Pennsylvania · www.keveyis.com
View All >>

M&A by Sector

Sector Buy # Value Sell # Value
Life Science 1 (100%) 9M (100%) - -
Total 1 $9M - -

By Geo

State/Country Buy Value Sell Value
United States 1 9M - -
  Pennsylvania 1 9M - -
Total 1 $9M - -

Top M&A Advisors

Financial Deals
Locust Walk Partners LLC
 1

Deal Values

buy # Total
< $100M 1 $9M
TOTAL $9M
Largest Taro Pharmaceutical Industries Ltd. - U.S. Rights to KEVEYIS
$9M (2016-12-23)

M&A Connections

Deals
Acquired from
Strategic(s)
100%
1 (100%)

Company Summary

SECTOR

Life Science

Revenue

31   41% 2020
22   23% 2019
18   158% 2018
7   2017
(millions of USD) Show More Show Less

Established

1996

 Subscribe to unlock this and 207,390
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More
1 Week Free Trial Learn More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB

Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.6K Private Equity Firms
  • 200K M&A Transactions
  • 203K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.

Related Lists for Strongbridge Biopharma

Pennsylvania Companies , Life Science Companies , United States Companies , Pennsylvania Life Science Companies , Pennsylvania Life Science with Acquisitions , Pennsylvania Life Science with Divestitures

Related Lists for Pennsylvania Companies

Largest Pennsylvania Companies , Acquisitive Pennsylvania Companies , Recently Acquired Pennsylvania Companies , Recently Sold Pennsylvania Companies , Private Pennsylvania Companies , Public Pennsylvania Companies , Acquired Pennsylvania Companies , PE Backed Pennsylvania Companies

Related Lists for Life Science Companies

Largest Life Science Companies , Acquisitive Life Science Companies , Recently Acquired Life Science Companies , Recently Sold Life Science Companies , Private Life Science Companies , Public Life Science Companies , Acquired Life Science Companies , PE Backed Life Science Companies

Related Lists for United States Companies

Largest United States Companies , Acquisitive United States Companies , Recently Acquired United States Companies , Recently Sold United States Companies , Private United States Companies , Public United States Companies , Acquired United States Companies , PE Backed United States Companies
Mergr

Product

Company

Legal